Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.
Location: United States, Pennsylvania, Wayne
Member count: 51-200
Total raised: $62M
Founded date: 2012
Investors 9
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 27.05.2016 | - | $20M | - | aislingcap... |
| 02.10.2014 | Series B | $21M | - | vcnewsdail... |
| 24.10.2012 | Series A | $21M | - | vcnewsdail... |
Mentions in press and media 14
| Date | Title | Description | Category | Author | Source |
| 07.12.2021 | Aclaris Th... | EMPOWERING PATIENTS THROUGH K... | - | - | marketscre... |
| 18.11.2021 | Aclaris Th... | EMPOWERING PATIENTS THROUGH K... | - | - | marketscre... |
| 27.05.2016 | Aclaris Th... | MALVERN, Pa., May 27, 2016 (GL... | - | - | aislingcap... |
| 18.08.2015 | Malvern bi... | Aclaris Therapeutics, a Malver... | - | - | technical.... |
| 02.10.2014 | Aclaris Th... | Aclaris Therapeutics, Inc., a ... | USA | - | finsmes.co... |
| 02.10.2014 | Aclaris Th... | MALVERN, PA, Privately-held ... | - | - | vcnewsdail... |
| 02.01.2014 | Biopharma ... | LXR agonists have generated in... | - | - | medcitynew... |
| 04.10.2013 | From gamif... | CardioReady (@CardioReady) is ... | - | - | medcitynew... |
| 24.10.2012 | Aclaris Th... | MALVERN, PA, Privately held ... | - | - | vcnewsdail... |
| 24.10.2012 | Dermatolog... | Stephen Tullman, who was an ex... | - | - | medcitynew... |
Show more